ATE430804T1 - Für eine prozessierungskomponente aus der n- terminalen region des hepatitis virus orf2 kodierendes nukleinsäurekonstrukt und antigenes polypeptid - Google Patents

Für eine prozessierungskomponente aus der n- terminalen region des hepatitis virus orf2 kodierendes nukleinsäurekonstrukt und antigenes polypeptid

Info

Publication number
ATE430804T1
ATE430804T1 AT01916744T AT01916744T ATE430804T1 AT E430804 T1 ATE430804 T1 AT E430804T1 AT 01916744 T AT01916744 T AT 01916744T AT 01916744 T AT01916744 T AT 01916744T AT E430804 T1 ATE430804 T1 AT E430804T1
Authority
AT
Austria
Prior art keywords
nucleic acid
processing component
acid construct
terminal region
hepatitis virus
Prior art date
Application number
AT01916744T
Other languages
German (de)
English (en)
Inventor
Fan Li
David Anderson
Damian Purcell
Original Assignee
Macfarlane Burnet Inst For Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macfarlane Burnet Inst For Med filed Critical Macfarlane Burnet Inst For Med
Application granted granted Critical
Publication of ATE430804T1 publication Critical patent/ATE430804T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/28011—Hepeviridae
    • C12N2770/28111—Hepevirus, e.g. hepatitis E virus
    • C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
AT01916744T 2000-03-31 2001-03-30 Für eine prozessierungskomponente aus der n- terminalen region des hepatitis virus orf2 kodierendes nukleinsäurekonstrukt und antigenes polypeptid ATE430804T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPQ6616A AUPQ661600A0 (en) 2000-03-31 2000-03-31 A nucleic acid construct and methods related thereto
PCT/AU2001/000353 WO2001073078A1 (en) 2000-03-31 2001-03-30 A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus orf2, and an antigenic polypeptide

Publications (1)

Publication Number Publication Date
ATE430804T1 true ATE430804T1 (de) 2009-05-15

Family

ID=3820712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01916744T ATE430804T1 (de) 2000-03-31 2001-03-30 Für eine prozessierungskomponente aus der n- terminalen region des hepatitis virus orf2 kodierendes nukleinsäurekonstrukt und antigenes polypeptid

Country Status (14)

Country Link
US (1) US7341723B2 (cg-RX-API-DMAC7.html)
EP (1) EP1274851B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003528614A (cg-RX-API-DMAC7.html)
KR (1) KR100768051B1 (cg-RX-API-DMAC7.html)
CN (1) CN1426472A (cg-RX-API-DMAC7.html)
AT (1) ATE430804T1 (cg-RX-API-DMAC7.html)
AU (1) AUPQ661600A0 (cg-RX-API-DMAC7.html)
CA (1) CA2407036A1 (cg-RX-API-DMAC7.html)
DE (1) DE60138612D1 (cg-RX-API-DMAC7.html)
HK (1) HK1052368A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA02009437A (cg-RX-API-DMAC7.html)
NZ (1) NZ521758A (cg-RX-API-DMAC7.html)
WO (1) WO2001073078A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200207769B (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101189B2 (en) 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
MXPA05000287A (es) 2002-07-05 2005-09-08 Leclerc Denis Particula viral adyuvante.
KR100641810B1 (ko) * 2004-04-23 2006-11-06 주식회사 포스코건설 충격흡수 및 복원 가능한 중간 스프링 설치 금속재 지주
US8906863B2 (en) 2009-02-27 2014-12-09 The Regents Of The University Of California Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector
US8906862B2 (en) 2009-02-27 2014-12-09 The Regents Of The University Of California Multiple antigen delivery system using hepatitis E virus-like particle
WO2010099547A1 (en) * 2009-02-27 2010-09-02 The Regents Of The University Of California Multiple antigen delivery system using hepatitis e virus-like particle

Also Published As

Publication number Publication date
JP2003528614A (ja) 2003-09-30
AUPQ661600A0 (en) 2000-05-04
KR20030015223A (ko) 2003-02-20
EP1274851A1 (en) 2003-01-15
MXPA02009437A (es) 2006-05-25
EP1274851B1 (en) 2009-05-06
WO2001073078A1 (en) 2001-10-04
KR100768051B1 (ko) 2007-10-18
ZA200207769B (en) 2004-02-10
EP1274851A4 (en) 2004-12-08
US7341723B2 (en) 2008-03-11
CN1426472A (zh) 2003-06-25
DE60138612D1 (de) 2009-06-18
NZ521758A (en) 2004-05-28
HK1052368A1 (zh) 2003-09-11
CA2407036A1 (en) 2001-10-04
US20030158138A1 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
DE60117978D1 (de) Modifizierung des hepatitis b kernantigens
DE60232577D1 (de) Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential
DK0835315T3 (da) Vaccine til porcint reproduktivt og respiratorisk syndrom virus
DK0414374T3 (da) Hidtil ukendte antigener og fremgangsmåder til fremstilling deraf
DK0561890T3 (da) DNA ekspressionssystemer baseret på alphavira
NZ545048A (en) Chimeric antigens for breaking host tolerance to foreign antigens
DK1829551T3 (da) Modificeret varmchokprotein-antigenpeptid-kompleks
DE69936977D1 (de) Durch polynukleinsäuren vom reproduktiven und respiratorischen syndromvirus des schweines kodierte proteine
MXPA02006888A (es) Flavivirus recombinantes y metodos para utilizar los mismos.
DE69333468D1 (de) Schützende antikörper induzierende antigene aus plasmodium falciparum
MXPA05005202A (es) Vacuna.
IT1180160B (it) Antigene di peptide protettivo
EP1015009A4 (en) attenuated VIF DNA immunization cassettes as genetic vaccines
NO993468D0 (no) Syntetiske peptid-epitoper fra proteinet fra Pre-M/M fra dengue-virus
DE60138612D1 (de) Alen region des hepatitis virus orf2 kodierendes nukleinsäurekonstrukt und antigenes polypeptid
IE870507L (en) Bovine virus diarrhea and hog cholera vaccines
YU45292A (sh) Različiti površinski proteini hepatitis b virusa koji obrazuju čestice
NO20041564L (no) Infeksios lakse anemi-virus vaksine
DE50212580D1 (de) Rekombinantes mva mit der fähigkeit zur expression von hcv struktur-antigenen
ATE71534T1 (de) Vakzine.
JP2003528614A5 (cg-RX-API-DMAC7.html)
KR890008318A (ko) 플라스모듐 팔시파룸의 재조합 히스티딘-고함유 단백질, 이의 제조방법 및 용도
CN1986562B (zh) 一种能增强动物抗体应答的多肽片段及其应用
Bakayev The Use of HBsAg and HBcAg particles of hepatitis B virus as carriers for presentation of heterologous epitopes to immune system
SE0002498D0 (sv) Papillomavirus vaccine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties